Jove
Visualize
Contact Us

Related Concept Videos

Clinical Trials01:16

Clinical Trials

9.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
9.8K
Clinical Trials: Overview01:11

Clinical Trials: Overview

3.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.9K
Hazard Ratio01:12

Hazard Ratio

304
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
304
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

37
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
37
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

207
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
207
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

49
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
49

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multidisciplinary Management of Women Suffering from Migraine: Rationale, Design and Results of a National Delphi Consensus.

Healthcare (Basel, Switzerland)·2026
Same author

Focused analysis of the surgical management for recurrence of internal rectal prolapse and obstructed defecation syndrome after stapled rectal resection procedures: a long-term single-center experience.

International journal of colorectal disease·2026
Same author

Neurophysiological, imaging and neurobiological markers of central fatigue in multiple sclerosis.

Brain communications·2026
Same author

A non-invasive neuromodulation tuned to regional neuronal activity.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2026
Same author

Scale-Free Neurodynamics as Functional Fingerprint of Brain Regions.

Bioengineering (Basel, Switzerland)·2026
Same author

A comprehensive scoring system for defecation disorders derived by merging various validated patient-reported outcome measures for fecal incontinence, chronic constipation, and obstructed defecation.

International journal of colorectal disease·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Oct 25, 2025

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
08:53

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Published on: June 6, 2025

879

tDCS randomized controlled trials in no-structural diseases: a quantitative review.

Eugenia Gianni1,2, Massimo Bertoli1,3, Ilaria Simonelli4

  • 1LET'S - ISTC - CNR, via Palestro 32, 00185, Rome, Italy.

Scientific Reports
|August 12, 2021
PubMed
Summary

Transcranial direct current stimulation (tDCS) shows moderate to high recommendation for treating depression and Multiple Sclerosis (MS) fatigue. This electroceutical therapy is safe, cost-effective, and promising for neurodynamic alterations.

More Related Videos

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
08:22

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability

Published on: October 7, 2017

8.3K
A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS
08:18

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS

Published on: December 26, 2015

17.8K

Related Experiment Videos

Last Updated: Oct 25, 2025

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
08:53

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Published on: June 6, 2025

879
Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
08:22

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability

Published on: October 7, 2017

8.3K
A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS
08:18

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS

Published on: December 26, 2015

17.8K

Area of Science:

  • Neuroscience
  • Neuromodulation
  • Electroceuticals

Background:

  • Growing number of high-quality randomized controlled trials (RCTs) on transcranial direct current stimulation (tDCS).
  • Increasing recognition of tDCS's electroceutical potential in neuroscientific research.
  • Potential for integrating tDCS into medical therapies under international guidelines.

Purpose of the Study:

  • To quantitatively review and estimate the recommendation strength of tDCS for non-structural diseases using GRADE criteria and PICO model.
  • To estimate the sham effect for future tDCS RCTs.
  • To evaluate tDCS effectiveness in psychophysical diseases with brain electrical activity imbalances.

Main Methods:

  • Quantitative review of Class 1 RCTs identified through literature search.
  • Meta-analyses conducted using a random-effects model for sub-selected pathologies.
  • Application of Grading of Recommendations, Assessment, Development and Evaluations (GRADE) criteria and PICO (population, intervention, comparison, outcome) model.

Main Results:

  • tDCS treatments for depression and fatigue in Multiple Sclerosis (MS) were ranked as moderately to highly recommendable.
  • Specific PICO variables reported: left vs. right dorsolateral prefrontal target (30 min/10 days) for depression; bilateral somatosensory vs. occipital target (15 min/5 days) for MS fatigue.
  • Meta-analysis indicated negligible side effects, low cost, and ease of use for tDCS procedures.

Conclusions:

  • High-quality evidence supports tDCS as a promising electroceutical treatment for diseases involving neurodynamics alterations.
  • tDCS demonstrates significant potential for managing depression and MS-related fatigue.
  • Sham effect data provided for power analysis in future tDCS RCTs.